Xone Ceff 250mg Injection contains Ceftriaxone, a third-generation cephalosporin antibiotic with broad-spectrum bactericidal activity. It is indicated for the treatment of various bacterial infections including lower respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, bone and joint infections, and septicemia. Ceftriaxone exerts its effect by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The 250mg dosage is suitable for mild to moderate infections and is administered via intramuscular or intravenous injection, ensuring rapid systemic absorption and effective plasma concentrations. Xone Ceff 250mg is effective against both Gram-positive and Gram-negative pathogens, including Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria gonorrhoeae. It is generally well tolerated; however, hypersensitivity reactions, local injection site pain, and gastrointestinal disturbances may occur. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Dose adjustment may be necessary in patients with severe renal or hepatic impairment. Xone Ceff 250mg Injection should be used under medical supervision, following susceptibility testing and clinical evaluation to ensure appropriate antimicrobial therapy and to minimize the development of resistance.